|
(1) Strategies against NSAID-induced
gastrointestinal side effects (part 1)
(PDF*
85K)
In the first in a series of three articles on minimising the gastrointestinal
risk associated with anti-inflammatory drugs, Fiona MacRae, Lisa
MacKenzie, Kenneth McColl and David Williams outline the available
safety and tolerability data supporting the main risk-minimisation
strategies
Pharmaceutical Journal, 14 February 2004, 187-189. Vol 272, no
7286
|
|
(2) Strategies against NSAID-induced
gastrointestinal side effects (part 2)
(PDF*
85K)
In this second article on the gastrointestinal risks associated
with anti-inflammatory drugs, Fiona MacRae, Lisa MacKenzie, Kenneth
McColl and David Williams discuss how efficacy, cost, compliance,
co-morbidities and concurrent medication affect the choice of
risk minimisation strategy
Pharmaceutical Journal, 21 February 2004, 219-221. Vol 272, no
7287
|
|
(3) How to change NSAID prescribing
(PDF*
210K)
So far, this series has discussed the evidence for strategies to minimise the gastrointestinal risk associated with non-steroidal anti-inflammatory drugs. In this final article, Fiona MacRae, Lisa MacKenzie, Kenneth McColl and David Williams look at how to implement change
Pharmaceutical Journal, 28 February 2004, 249-252. Vol 272, no
7288
|
|
| • Most
photographs have been removed from the PDF files for copyright reasons.
• The contents of the Pharmaceutical
Journal, associated publications and all PDF files are the property
of the Royal Pharmaceutical Society. See Copyright
for our rights. |
| Photocopies
Photocopies of articles can be ordered from the Society’s library
(library@rpsgb.org.uk);
for details click here |
| Reprints
Details on multiple reprints of the original articles are here |
|
